Yi Shen, Liping Liu, Shuang Ma, Xiaohua Ban, Shaoxian Chen, Zhuozhi Dai, Shaofan Lin, Kainan Huang, Xiaohui Duan, Daiying Lin
{"title":"基于多参数mri的放射组学和深度学习鉴别子宫浆液性癌和子宫内膜样癌:一项多中心回顾性研究。","authors":"Yi Shen, Liping Liu, Shuang Ma, Xiaohua Ban, Shaoxian Chen, Zhuozhi Dai, Shaofan Lin, Kainan Huang, Xiaohui Duan, Daiying Lin","doi":"10.3389/fonc.2025.1655384","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Uterine serous carcinoma (USC) and endometrioid endometrial carcinoma (EEC) are distinct subtypes of endometrial cancer with markedly different prognoses and management strategies. Accurate preoperative differentiation between USC and EEC is of great significance for tailoring surgical planning and adjuvant therapy.</p><p><strong>Purpose: </strong>To develop and validate a multiparametric MRI-based radiomics and deep learning (DL) model for preoperative distinguishing USC from EEC.</p><p><strong>Methods: </strong>A total of 210 patients (68 USCs and 142 EECs) from four hospitals who underwent preoperative MRI were enrolled in this retrospective study. Features from radiomics and deep learning were extracted using T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and contrast enhanced MRI (CE-MRI). The least absolute shrinkage and selection operator (LASSO) analysis was employed to identify the most valuable features. Clinical-radiological characteristics, radiomics and DL features were constructed using a support vector machine (SVM) algorithm. The models were evaluated using receiver operating characteristic (ROC) and decision curve analysis (DCA).</p><p><strong>Results: </strong>The all-combined model of clinical-radiological characteristics, radiomics and DL features showed better discrimination ability than either alone. The all-combined model demonstrated superior classification performance, achieving an AUC of 0.957 (95% CI: 0.904-1.000) on the internal-testing set and an AUC of 0.880 (95% CI: 0.800-0.961) on the external-testing set. The DLR model demonstrated superior predictive performance compared to the clinical-radiological model, although the differences were not statistically significant in both the internal-testing set (AUC = 0.908 vs. 0.861, <i>p</i> = 0.504) and the external-testing set (AUC = 0.767 vs. 0.700, <i>p</i> = 0.499). The DCA revealed that the all-combined model illustrated the best overall net benefit in clinical application.</p><p><strong>Conclusion: </strong>The integrated model, combining multiparametric MRI-based radiomics, deep learning features, and clinical-radiological characteristics, may be utilized for the preoperative differentiation of USC from EEC.</p>","PeriodicalId":12482,"journal":{"name":"Frontiers in Oncology","volume":"15 ","pages":"1655384"},"PeriodicalIF":3.5000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12540183/pdf/","citationCount":"0","resultStr":"{\"title\":\"Multiparametric MRI-based radiomics and deep learning for differentiating uterine serous carcinoma from endometrioid carcinoma: a multicenter retrospective study.\",\"authors\":\"Yi Shen, Liping Liu, Shuang Ma, Xiaohua Ban, Shaoxian Chen, Zhuozhi Dai, Shaofan Lin, Kainan Huang, Xiaohui Duan, Daiying Lin\",\"doi\":\"10.3389/fonc.2025.1655384\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Uterine serous carcinoma (USC) and endometrioid endometrial carcinoma (EEC) are distinct subtypes of endometrial cancer with markedly different prognoses and management strategies. Accurate preoperative differentiation between USC and EEC is of great significance for tailoring surgical planning and adjuvant therapy.</p><p><strong>Purpose: </strong>To develop and validate a multiparametric MRI-based radiomics and deep learning (DL) model for preoperative distinguishing USC from EEC.</p><p><strong>Methods: </strong>A total of 210 patients (68 USCs and 142 EECs) from four hospitals who underwent preoperative MRI were enrolled in this retrospective study. Features from radiomics and deep learning were extracted using T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and contrast enhanced MRI (CE-MRI). The least absolute shrinkage and selection operator (LASSO) analysis was employed to identify the most valuable features. Clinical-radiological characteristics, radiomics and DL features were constructed using a support vector machine (SVM) algorithm. The models were evaluated using receiver operating characteristic (ROC) and decision curve analysis (DCA).</p><p><strong>Results: </strong>The all-combined model of clinical-radiological characteristics, radiomics and DL features showed better discrimination ability than either alone. The all-combined model demonstrated superior classification performance, achieving an AUC of 0.957 (95% CI: 0.904-1.000) on the internal-testing set and an AUC of 0.880 (95% CI: 0.800-0.961) on the external-testing set. The DLR model demonstrated superior predictive performance compared to the clinical-radiological model, although the differences were not statistically significant in both the internal-testing set (AUC = 0.908 vs. 0.861, <i>p</i> = 0.504) and the external-testing set (AUC = 0.767 vs. 0.700, <i>p</i> = 0.499). The DCA revealed that the all-combined model illustrated the best overall net benefit in clinical application.</p><p><strong>Conclusion: </strong>The integrated model, combining multiparametric MRI-based radiomics, deep learning features, and clinical-radiological characteristics, may be utilized for the preoperative differentiation of USC from EEC.</p>\",\"PeriodicalId\":12482,\"journal\":{\"name\":\"Frontiers in Oncology\",\"volume\":\"15 \",\"pages\":\"1655384\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12540183/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fonc.2025.1655384\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fonc.2025.1655384","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:子宫浆液性癌(USC)和子宫内膜样子宫内膜癌(EEC)是子宫内膜癌的不同亚型,预后和治疗策略明显不同。术前准确区分USC和EEC对制定手术计划和辅助治疗具有重要意义。目的:开发并验证一种基于多参数mri的放射组学和深度学习(DL)模型,用于术前区分USC和EEC。方法:对4家医院术前行MRI检查的210例患者(68例USCs, 142例EECs)进行回顾性研究。利用t2加权成像(T2WI)、弥散加权成像(DWI)和增强MRI (CE-MRI)提取放射组学和深度学习的特征。最小绝对收缩和选择算子(LASSO)分析被用来识别最有价值的特征。使用支持向量机(SVM)算法构建临床放射学特征、放射组学特征和DL特征。采用受试者工作特征(ROC)和决策曲线分析(DCA)对模型进行评价。结果:临床-放射学特征、放射组学特征和DL特征的综合模型比单独模型具有更好的鉴别能力。综合模型表现出优异的分类性能,在内部测试集上的AUC为0.957 (95% CI: 0.904-1.000),在外部测试集上的AUC为0.880 (95% CI: 0.800-0.961)。与临床放射学模型相比,DLR模型表现出更好的预测性能,尽管在内部测试集(AUC = 0.908 vs. 0.861, p = 0.504)和外部测试集(AUC = 0.767 vs. 0.700, p = 0.499)中差异均无统计学意义。DCA显示,全联合模型在临床应用中表现出最佳的总净效益。结论:该综合模型结合多参数mri放射组学、深度学习特征和临床放射学特征,可用于USC与EEC的术前鉴别。
Multiparametric MRI-based radiomics and deep learning for differentiating uterine serous carcinoma from endometrioid carcinoma: a multicenter retrospective study.
Background: Uterine serous carcinoma (USC) and endometrioid endometrial carcinoma (EEC) are distinct subtypes of endometrial cancer with markedly different prognoses and management strategies. Accurate preoperative differentiation between USC and EEC is of great significance for tailoring surgical planning and adjuvant therapy.
Purpose: To develop and validate a multiparametric MRI-based radiomics and deep learning (DL) model for preoperative distinguishing USC from EEC.
Methods: A total of 210 patients (68 USCs and 142 EECs) from four hospitals who underwent preoperative MRI were enrolled in this retrospective study. Features from radiomics and deep learning were extracted using T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and contrast enhanced MRI (CE-MRI). The least absolute shrinkage and selection operator (LASSO) analysis was employed to identify the most valuable features. Clinical-radiological characteristics, radiomics and DL features were constructed using a support vector machine (SVM) algorithm. The models were evaluated using receiver operating characteristic (ROC) and decision curve analysis (DCA).
Results: The all-combined model of clinical-radiological characteristics, radiomics and DL features showed better discrimination ability than either alone. The all-combined model demonstrated superior classification performance, achieving an AUC of 0.957 (95% CI: 0.904-1.000) on the internal-testing set and an AUC of 0.880 (95% CI: 0.800-0.961) on the external-testing set. The DLR model demonstrated superior predictive performance compared to the clinical-radiological model, although the differences were not statistically significant in both the internal-testing set (AUC = 0.908 vs. 0.861, p = 0.504) and the external-testing set (AUC = 0.767 vs. 0.700, p = 0.499). The DCA revealed that the all-combined model illustrated the best overall net benefit in clinical application.
Conclusion: The integrated model, combining multiparametric MRI-based radiomics, deep learning features, and clinical-radiological characteristics, may be utilized for the preoperative differentiation of USC from EEC.
期刊介绍:
Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.